PodcastIntel
Sign in Get Started Free
Acquired
Acquired

Novo Nordisk (Ozempic)

Jan 22, 2024 · 3h 44m
AI Summary
  • Novo Nordisk, maker of Ozempic and Wegovy, is Europe's most valuable company.
  • The Danish firm is a leader in diabetes and obesity treatments.
  • Novo Nordisk's success highlights the massive market and impact of new pharmaceutical innovations.

More from Acquired

Acquired
Mar 2, 2026 · 4h 29m
Acquired
Jan 27, 2026 · 4h 17m
Acquired
Nov 24, 2025 · 4h 4m
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Acquired and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →